Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

6.48
Delayed Data
As of Sep 02
 +0.54 / +9.09%
Today’s Change
3.33
Today|||52-Week Range
6.85
+55.40%
Year-to-Date

Today’s Trading

Previous close5.94
Today’s open6.06
Day’s range6.06 - 6.50
Volume471,078
Average volume (3 months)480,622
Market cap$359.4M
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-100.00%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+31.00%
P/E ratioNM
Price/Sales2.68
Price/Book5.92

Competitors

 Today’s
change
Today’s
% change
NVTAInvitae Corp-0.14-1.42%
GNMKGenMark Diagnostics ...+0.15+1.55%
CTICCTi Biopharma Corp+0.05+3.27%
RDNTRadNet Inc+0.19+3.20%
Data as of 09/02/2015

Financials

Next reporting dateOctober 21, 2015
EPS forecast (this quarter)$0.00
Annual revenue (last year)$87.1M
Annual profit (last year)$1.1M
Net profit margin1.30%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. VanOort
Chief Operating Officer
Robert J. Shovlin
Corporate headquarters
Fort Myers, Florida

Forecasts

Partner Offers